0 Yorumlar
0 hisse senetleri
242 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Adalimumab Biosimilar Market Accelerates as Cost-Effective Biologic Therapies Expand Access to Autoimmune Disease TreatmentAccording to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. For generating the Adalimumab Biosimilar...0 Yorumlar 0 hisse senetleri 258 Views 0 önizleme
-
Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The large scale Adalimumab Biosimilar Marketing report...0 Yorumlar 0 hisse senetleri 448 Views 0 önizleme
-
Immunoglobulins Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Immunodeficiency and Autoimmune DisordersAccording to the latest report published by Data Bridge Market Research, the Immunoglobulins Market Global immunoglobulins market size was valued at USD 16.06 billion in 2024 and is projected to reach USD 27.69 billion by 2032, with a CAGR of 7.05% during the forecast period of 2025 to 2032. To impart a supreme quality to this persuasive Immunoglobulins Market report, unswerving...0 Yorumlar 0 hisse senetleri 530 Views 0 önizleme
-
Janus Kinase (JAK) Inhibitor Drugs Market Advances with Expanding Use of Targeted Therapies for Autoimmune and Inflammatory DisordersAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030 Global Janus Kinases (JAKs)...0 Yorumlar 0 hisse senetleri 213 Views 0 önizleme
-
Janus Kinase (JAK) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. To impart a supreme quality to...0 Yorumlar 0 hisse senetleri 384 Views 0 önizleme
-
Janus Kinases (JAKs) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Autoimmune Disorders and Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. This Janus Kinases (JAKs)...0 Yorumlar 0 hisse senetleri 502 Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek